Company
Headquarters: Beijing, China
Employees: 3,877
€793.9 Million
EUR as of July 1, 2024
US$852.7 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
| AbbVie | $295.34 B |
| AstraZeneca | $236.45 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China, Hong Kong, and internationally. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Tong Ren Tang Technologies Co. Ltd. has the following listings and related stock indices.
Stock: FSX: TNG wb_incandescent